Инновационная медицина Кубани (Feb 2025)
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
- Ashot A. Avagimyan,
- Mohammad Sheibani,
- Artem I. Trofimenko,
- Evgenii E. Lysov,
- Farida M. Khamidova,
- Anahit Z. Aznauryan,
- Lilit M. Sukiasyan,
- Karmen T. Sahakyan,
- Tamara R. Gevorgyan,
- Marina R. Tatoyan,
- Gayane L. Mkrtchyan,
- Goharik L. Meltonyan,
- Anna R. Petrosyan,
- Ludmila A. Martemyanova,
- Ruzanna R. Petrosyan,
- Olga I. Urazova,
- Nana V. Pogosova,
- Nizal Sarrafzadegan
Affiliations
- Ashot A. Avagimyan
- Yerevan State Medical University after M. Heratsi
- Mohammad Sheibani
- Iran University of Medical Sciences
- Artem I. Trofimenko
- Kuban State Medical University
- Evgenii E. Lysov
- Kuban State Medical University
- Farida M. Khamidova
- Samarkand State Medical University
- Anahit Z. Aznauryan
- Yerevan State Medical University after M. Heratsi
- Lilit M. Sukiasyan
- Yerevan State Medical University after M. Heratsi
- Karmen T. Sahakyan
- Yerevan State Medical University after M. Heratsi
- Tamara R. Gevorgyan
- Yerevan State Medical University after M. Heratsi
- Marina R. Tatoyan
- Yerevan State Medical University after M. Heratsi
- Gayane L. Mkrtchyan
- Yerevan State Medical University after M. Heratsi
- Goharik L. Meltonyan
- Yerevan State Medical University after M. Heratsi
- Anna R. Petrosyan
- Yerevan State Medical University after M. Heratsi
- Ludmila A. Martemyanova
- Gomel State Medical University
- Ruzanna R. Petrosyan
- Lebanese American University
- Olga I. Urazova
- Siberian State Medical University
- Nana V. Pogosova
- National Medical Research Centre of Cardiology after Acad. E.I. Chazov; Patrice Lumumba Peoples’ Friendship University of Russia
- Nizal Sarrafzadegan
- Cardiovascular Research Institute, Isfahan University of Medical Sciences
- DOI
- https://doi.org/10.35401/2541-9897-2025-10-1-101-109
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 101 – 109
Abstract
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are now uncovering new possibilities in the field of internal medicine owing to their diverse protective effects. In the second part of the literature review, we explore potential applications of SGLT2i in hepatology, neurology, ophthalmology, and oncology, mechanisms of action of such drugs as dapagliflozin, empagliflozin, canagliflozin, etc, and their effect on different organs and systems.
Keywords
- hepatoprotection
- neuroprotection
- retinoprotection
- oncoprotection
- dapagliflozin
- empagliflozin
- canagliflozin
